HURA READ THE FULL HURA RESEARCH REPORT Operational and Financial Results On April 1st, 2025, TuHURA Biosciences, Inc.

Artificial intelligence offers breakthroughs in life sciences, yet issues of bias, interpretability, and ethics pose ...

Pfizer on Monday said it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

The discovery of drug apparatus and other by-products along the Udu coastline in Macuata indicates a growing threat to the ...

OSU scientists created nanoparticles that deliver anti-inflammatory drugs across the blood-brain barrier, offering hope for ...

Recursion Pharmaceuticals, a trailblazing TechBio company, has made a significant stride in the realm of oncology by dosing the first patient in its Phase 1 clinical trial for a potential B-cell ...

Recuresion Pharma (RXRX) stock and other AI-driven biotechs surge as FDA embraces computational models over animal testing ...

Certara’s AI strategy and FDA-aligned offerings fuel growth across drug discovery and trials, with expanding margins. Read ...

However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...

Big Pharma and biotech startups alike are counting on AI to speed the process of drug discovery and make their operations ...

RedChip Companies will air interviews with Bullfrog AI Holdings, Inc. (Nasdaq:BFRG) and Connect Biopharma Holdings Limited (Nasdaq:CNTB) and on the RedChip Small Stocks, Big Money™ show, a sponsored ...

CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...